Imelda Meyer-Wilmes

Title: Imelda Meyer-Wilmes: Innovator in Pharmaceutical Chemistry

Introduction

Imelda Meyer-Wilmes is a notable inventor based in Haag, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical use. Her work focuses on improving the production methods of important pharmaceutical ingredients.

Latest Patents

Meyer-Wilmes holds a patent for "Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof." This invention presents a new polymorphic form of olopatadine hydrochloride, a selective histamine H1-receptor antagonist used to treat ocular symptoms of seasonal allergic conjunctivitis. The patent outlines methods for large-scale production of olopatadine that are cost-effective and reduce impurities. Notably, her methods eliminate the need for the hazardous base, butyllithium, which has been used in previous reactions for synthesizing olopatadine.

Career Highlights

Throughout her career, Imelda Meyer-Wilmes has worked with reputable organizations such as Azad Pharmaceutical Ingredients AG and Universität Zürich. Her experience in these institutions has allowed her to refine her expertise in pharmaceutical development and production.

Collaborations

Meyer-Wilmes has collaborated with esteemed colleagues, including Thomas Bader and Hans-Ulrich Bichsel. These partnerships have contributed to her innovative approaches in the pharmaceutical field.

Conclusion

Imelda Meyer-Wilmes is a pioneering inventor whose work in pharmaceutical chemistry has led to significant advancements in the production of olopatadine. Her contributions continue to impact the field positively, showcasing her dedication to innovation and improvement in medical treatments.